Chung, Ik-Joo
Chonnam National University · Chonnam National University Hwasun Hospital
3 papers on CoChatORCID 0000-0003-0479-8067
Most cited papers
- Verified
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
Noh, S. H., Park, S. R., Yang, H.-K., Chung, H. C., Chung, I.-J., Kim, S.-W., Kim, H.-H., Choi, J.-H., Kim, H.-K., Yu, W., et al. (2014) · The Lancet Oncology
Gastric Cancer Management and OutcomesIntraperitoneal and Appendiceal Malignancies
Cited by 1,049
- Verified
Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin
Zheng, J. H., Nguyen, V. H., Jiang, S.-N., Park, S.-H., Tan, W., Hong, S. H., Shin, M. G., Chung, I.-J., Hong, Y., Bom, H.-S., et al. (2017) · Science Translational Medicine
Bacterial Cancer TherapyImmunotherapy and Immune Responses
Cited by 588
- Verified
Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer
Hong, C., Sun, E., Choi, J., Kim, D., Kim, J., Ryu, K., Shim, H., Hwang, J., Bae, W., Kim, H., et al. (2020) · Cancer Science
Fibroblast Growth Factor ResearchHER2/EGFR in Cancer Research
Cited by 35
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free